Dysregulation of Glucagon Secretion by Hyperglycemia-Induced Sodium-Dependent Reduction of ATP Production

Jakob G. Knudsen; Alexander Hamilton; Reshma Ramracheya; Andrei I. Tarasov; Melissa Brereton; Elizabeth Haythorne; Margarita V. Chibalina; Peter Spégel; Hindrik Mulder; Quan Zhang; Frances M. Ashcroft; Julie Adam; Patrik Rorsman

doi:10.1016/j.cmet.2018.10.003

Dysregulation of Glucagon Secretion by Hyperglycemia-Induced Sodium-Dependent Reduction of ATP Production

Jakob G. Knudsen, Alexander Hamilton, Reshma Ramracheya, Andrei I. Tarasov, Melissa Brereton, Elizabeth Haythorne, Margarita V. Chibalina, Peter Spégel, Hindrik Mulder, Quan Zhang, Frances M. Ashcroft, Julie Adam, Patrik Rorsman

22 Citationer (Scopus)

2 Downloads (Pure)

Abstract

Diabetes is a bihormonal disorder resulting from combined insulin and glucagon secretion defects. Mice lacking fumarase (Fh1) in their β cells (Fh1βKO mice) develop progressive hyperglycemia and dysregulated glucagon secretion similar to that seen in diabetic patients (too much at high glucose and too little at low glucose). The glucagon secretion defects are corrected by low concentrations of tolbutamide and prevented by the sodium-glucose transport (SGLT) inhibitor phlorizin. These data link hyperglycemia, intracellular Na+ accumulation, and acidification to impaired mitochondrial metabolism, reduced ATP production, and dysregulated glucagon secretion. Protein succination, reflecting reduced activity of fumarase, is observed in α cells from hyperglycemic Fh1βKO and β-V59M gain-of-function KATP channel mice, diabetic Goto-Kakizaki rats, and patients with type 2 diabetes. Succination is also observed in renal tubular cells and cardiomyocytes from hyperglycemic Fh1βKO mice, suggesting that the model can be extended to other SGLT-expressing cells and may explain part of the spectrum of diabetic complications.

Originalsprog	Engelsk
Tidsskrift	Cell Metabolism
Vol/bind	29
Udgave nummer	2
Sider (fra-til)	430-442, e1-e4
ISSN	1550-4131
DOI	https://doi.org/10.1016/j.cmet.2018.10.003
Status	Udgivet - 5 feb. 2019
Udgivet eksternt	Ja

FN’s Verdensmål

Dette resultat bidrager til følgende verdensmål

Adgang til dokumentet

10.1016/j.cmet.2018.10.003Licens: CC BY

Dysregulation of Glucagon Secretion by Hyperglycemia-Induced Sodium-Dependent Reduction of ATP ProductionForlagets udgivne version, 7,01 MBLicens: CC BY

Citationsformater

Knudsen, J. G., Hamilton, A., Ramracheya, R., Tarasov, A. I., Brereton, M., Haythorne, E., Chibalina, M. V., Spégel, P., Mulder, H., Zhang, Q., Ashcroft, F. M., Adam, J., & Rorsman, P. (2019). Dysregulation of Glucagon Secretion by Hyperglycemia-Induced Sodium-Dependent Reduction of ATP Production. Cell Metabolism, 29(2), 430-442, e1-e4. https://doi.org/10.1016/j.cmet.2018.10.003

Knudsen, JG, Hamilton, A, Ramracheya, R, Tarasov, AI, Brereton, M, Haythorne, E, Chibalina, MV, Spégel, P, Mulder, H, Zhang, Q, Ashcroft, FM, Adam, J & Rorsman, P 2019, 'Dysregulation of Glucagon Secretion by Hyperglycemia-Induced Sodium-Dependent Reduction of ATP Production', Cell Metabolism, bind 29, nr. 2, s. 430-442, e1-e4. https://doi.org/10.1016/j.cmet.2018.10.003

@article{7065da0b268e483d86f63c8ad7ce1137,

title = "Dysregulation of Glucagon Secretion by Hyperglycemia-Induced Sodium-Dependent Reduction of ATP Production",

abstract = "Diabetes is a bihormonal disorder resulting from combined insulin and glucagon secretion defects. Mice lacking fumarase (Fh1) in their β cells (Fh1βKO mice) develop progressive hyperglycemia and dysregulated glucagon secretion similar to that seen in diabetic patients (too much at high glucose and too little at low glucose). The glucagon secretion defects are corrected by low concentrations of tolbutamide and prevented by the sodium-glucose transport (SGLT) inhibitor phlorizin. These data link hyperglycemia, intracellular Na+ accumulation, and acidification to impaired mitochondrial metabolism, reduced ATP production, and dysregulated glucagon secretion. Protein succination, reflecting reduced activity of fumarase, is observed in α cells from hyperglycemic Fh1βKO and β-V59M gain-of-function KATP channel mice, diabetic Goto-Kakizaki rats, and patients with type 2 diabetes. Succination is also observed in renal tubular cells and cardiomyocytes from hyperglycemic Fh1βKO mice, suggesting that the model can be extended to other SGLT-expressing cells and may explain part of the spectrum of diabetic complications.",

author = "Knudsen, {Jakob G.} and Alexander Hamilton and Reshma Ramracheya and Tarasov, {Andrei I.} and Melissa Brereton and Elizabeth Haythorne and Chibalina, {Margarita V.} and Peter Sp{\'e}gel and Hindrik Mulder and Quan Zhang and Ashcroft, {Frances M.} and Julie Adam and Patrik Rorsman",

year = "2019",

month = feb,

day = "5",

doi = "10.1016/j.cmet.2018.10.003",

language = "English",

volume = "29",

pages = "430--442, e1--e4",

journal = "Cell Metabolism",

issn = "1550-4131",

publisher = "Cell Press",

number = "2",

}

TY - JOUR

T1 - Dysregulation of Glucagon Secretion by Hyperglycemia-Induced Sodium-Dependent Reduction of ATP Production

AU - Knudsen, Jakob G.

AU - Hamilton, Alexander

AU - Ramracheya, Reshma

AU - Tarasov, Andrei I.

AU - Brereton, Melissa

AU - Haythorne, Elizabeth

AU - Chibalina, Margarita V.

AU - Spégel, Peter

AU - Mulder, Hindrik

AU - Zhang, Quan

AU - Ashcroft, Frances M.

AU - Adam, Julie

AU - Rorsman, Patrik

PY - 2019/2/5

Y1 - 2019/2/5

N2 - Diabetes is a bihormonal disorder resulting from combined insulin and glucagon secretion defects. Mice lacking fumarase (Fh1) in their β cells (Fh1βKO mice) develop progressive hyperglycemia and dysregulated glucagon secretion similar to that seen in diabetic patients (too much at high glucose and too little at low glucose). The glucagon secretion defects are corrected by low concentrations of tolbutamide and prevented by the sodium-glucose transport (SGLT) inhibitor phlorizin. These data link hyperglycemia, intracellular Na+ accumulation, and acidification to impaired mitochondrial metabolism, reduced ATP production, and dysregulated glucagon secretion. Protein succination, reflecting reduced activity of fumarase, is observed in α cells from hyperglycemic Fh1βKO and β-V59M gain-of-function KATP channel mice, diabetic Goto-Kakizaki rats, and patients with type 2 diabetes. Succination is also observed in renal tubular cells and cardiomyocytes from hyperglycemic Fh1βKO mice, suggesting that the model can be extended to other SGLT-expressing cells and may explain part of the spectrum of diabetic complications.

AB - Diabetes is a bihormonal disorder resulting from combined insulin and glucagon secretion defects. Mice lacking fumarase (Fh1) in their β cells (Fh1βKO mice) develop progressive hyperglycemia and dysregulated glucagon secretion similar to that seen in diabetic patients (too much at high glucose and too little at low glucose). The glucagon secretion defects are corrected by low concentrations of tolbutamide and prevented by the sodium-glucose transport (SGLT) inhibitor phlorizin. These data link hyperglycemia, intracellular Na+ accumulation, and acidification to impaired mitochondrial metabolism, reduced ATP production, and dysregulated glucagon secretion. Protein succination, reflecting reduced activity of fumarase, is observed in α cells from hyperglycemic Fh1βKO and β-V59M gain-of-function KATP channel mice, diabetic Goto-Kakizaki rats, and patients with type 2 diabetes. Succination is also observed in renal tubular cells and cardiomyocytes from hyperglycemic Fh1βKO mice, suggesting that the model can be extended to other SGLT-expressing cells and may explain part of the spectrum of diabetic complications.

U2 - 10.1016/j.cmet.2018.10.003

DO - 10.1016/j.cmet.2018.10.003

M3 - Journal article

C2 - 30415925

SN - 1550-4131

VL - 29

SP - 430-442, e1-e4

JO - Cell Metabolism

JF - Cell Metabolism

IS - 2

ER -

Dysregulation of Glucagon Secretion by Hyperglycemia-Induced Sodium-Dependent Reduction of ATP Production

Abstract

FN’s Verdensmål

Adgang til dokumentet

Fingeraftryk

Citationsformater